These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 31097014)

  • 1. Epigenetics in cancer therapy and nanomedicine.
    Roberti A; Valdes AF; Torrecillas R; Fraga MF; Fernandez AF
    Clin Epigenetics; 2019 May; 11(1):81. PubMed ID: 31097014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenome-based personalized medicine in human cancer.
    Yan W; Herman JG; Guo M
    Epigenomics; 2016 Jan; 8(1):119-33. PubMed ID: 26344672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of epigenetics in malignant pleural mesothelioma.
    Vandermeers F; Neelature Sriramareddy S; Costa C; Hubaux R; Cosse JP; Willems L
    Lung Cancer; 2013 Sep; 81(3):311-318. PubMed ID: 23790315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the potential of epigenetic therapy to target solid tumors.
    Ahuja N; Easwaran H; Baylin SB
    J Clin Invest; 2014 Jan; 124(1):56-63. PubMed ID: 24382390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of epigenetic therapy in solid tumours--lessons from the past.
    Azad N; Zahnow CA; Rudin CM; Baylin SB
    Nat Rev Clin Oncol; 2013 May; 10(5):256-66. PubMed ID: 23546521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic therapy for solid tumors: from bench science to clinical trials.
    Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
    Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Deacetylase Inhibitors in Cancer Therapy.
    Sun Y; Sun Y; Yue S; Wang Y; Lu F
    Curr Top Med Chem; 2018; 18(28):2420-2428. PubMed ID: 30526462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy.
    Chen F; Shi Y; Zhang J; Liu Q
    Curr Drug Targets; 2020; 21(11):1084-1098. PubMed ID: 32410563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising strategies: Combination of epigenetic inhibitors for cancer therapy.
    Gronemeyer H
    Int J Cancer; 2020 Nov; 147(10):2656-2657. PubMed ID: 32599650
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases.
    Fandy TE
    Curr Med Chem; 2009; 16(17):2075-85. PubMed ID: 19519382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological targeting of the cancer epigenome.
    Mabe NW; Perry JA; Malone CF; Stegmaier K
    Nat Cancer; 2024 Jun; 5(6):844-865. PubMed ID: 38937652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics and oncology.
    Mummaneni P; Shord SS
    Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in nanomedicine-based delivery of histone deacetylase inhibitors for cancer therapy.
    Hafez DA; Hassanin IA; Teleb M; Khattab SN; Elkhodairy KA; Elzoghby AO
    Nanomedicine (Lond); 2021 Oct; 16(25):2305-2325. PubMed ID: 34551585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics in radiotherapy: where are we heading?
    Smits KM; Melotte V; Niessen HE; Dubois L; Oberije C; Troost EG; Starmans MH; Boutros PC; Vooijs M; van Engeland M; Lambin P
    Radiother Oncol; 2014 May; 111(2):168-77. PubMed ID: 24861629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma epigenetics: novel mechanisms, markers, and medicines.
    Lee JJ; Murphy GF; Lian CG
    Lab Invest; 2014 Aug; 94(8):822-38. PubMed ID: 24978641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer.
    Mohammad HP; Barbash O; Creasy CL
    Nat Med; 2019 Mar; 25(3):403-418. PubMed ID: 30842676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epi-drugs as triple-negative breast cancer treatment.
    Idrissou M; Sanchez A; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
    Epigenomics; 2020 Apr; 12(8):725-742. PubMed ID: 32396394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic drugs take on cancer.
    Kaiser J
    Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.